Summary: Recent research shows that Alzheimer’s disease and age-related cognitive decline are not unavoidable consequences of aging. Large clinical trials demonstrate that targeted lifestyle interventions—regular physical activity, heart-healthy diets, social engagement and cognitive stimulation—can improve brain function and slow decline. These approaches mirror proven strategies for reducing cardiovascular disease and some cancers, indicating broad benefits for public health and major opportunities for prevention-focused policy.
The evidence supports organized, scalable efforts by clinicians, public health officials and policymakers to implement lifestyle-based programs that reduce the long-term burden of dementia on individuals, families and health systems.
Key Facts
- Preventable Risk: Up to 45% of dementia risk is associated with modifiable lifestyle and environmental factors.
- Clinical Evidence: Large randomized trials—U.S. POINTER and Finnish FINGER—show that structured, multidomain lifestyle changes improve cognition in at-risk older adults.
- Broader Impact: Modeling suggests modest reductions in key risk factors could cut national dementia burden by as much as 15%.
Source: FAU
Current burden: About 7.2 million Americans aged 65 and older now live with Alzheimer’s disease. That number is projected to rise to roughly 13.8 million by 2060. These projections reflect more than demographic change—they signal a growing public health crisis that calls for preventive action.
Chronological age remains the strongest known risk factor for cognitive decline, but evidence increasingly shows that loss of cognitive function is not an inevitable part of aging. Researchers at Florida Atlantic University’s Charles E. Schmidt College of Medicine emphasize prevention through lifestyle modification as a practical and evidence-based path to protect brain health.
In a commentary in The American Journal of Medicine, the authors call on clinicians, public health professionals and policymakers to coordinate programs that support lifestyle interventions shown to reduce cognitive decline. They point to landmark trials and growing mechanistic understanding to justify immediate action.
“While deaths from cardiovascular disease have declined since 2000, deaths from Alzheimer’s disease have surged by more than 140%,” said Charles H. Hennekens, M.D., FACPM, FACC, a co-author and senior advisor at the Schmidt College of Medicine. “At the same time, it is estimated that up to 45% of dementia risk could be attributed to modifiable lifestyle and environmental factors.”
Lifestyle risks that contribute to cognitive decline include physical inactivity, poor diet, obesity, excessive alcohol use, smoking, and medical conditions such as hypertension, diabetes, dyslipidemia and depression, as well as social isolation and limited intellectual engagement. The authors note that the same therapeutic lifestyle changes long recommended to reduce cardiovascular and cancer risk appear to confer benefits for brain health as well—often with additive effects when multiple risks are addressed together.
The commentary highlights results from POINTER, the first large-scale randomized U.S. trial testing whether an intensive, team-supported lifestyle program can improve cognition in older adults at high risk of decline. Over two years, participants randomized to a structured, multidomain intervention experienced statistically significant and clinically meaningful improvements in global cognition, with particularly strong gains in executive functions such as memory, attention, planning and decision-making.
POINTER’s program emphasized regular physical activity, a diet combining Mediterranean and DASH principles, ongoing cognitive stimulation and stronger social engagement—delivered via professional coaching and group support. These findings align with the earlier Finnish FINGER trial, which reported cognitive benefits from a similar multidomain lifestyle approach in participants with elevated cardiovascular risk.
The authors discuss plausible biological mechanisms: regular exercise raises brain-derived neurotrophic factor and supports hippocampal health, improves cerebral blood flow and reduces inflammation; Mediterranean- and DASH-style diets lower oxidative stress and improve insulin sensitivity and vascular risk; smoking cessation helps preserve brain structure and white matter; and sustained social and cognitive engagement promotes neuroplasticity and mental resilience.
“The implications for clinical practice, public health and government policy are potentially enormous,” said Parvathi Perumareddi, D.O., co-author and associate professor of family medicine. “Clinicians now have evidence-based, generally low-risk, and cost-effective tools to help patients prevent or slow cognitive decline—tools that extend beyond pharmacologic options. Public health agencies can adapt the frameworks used in POINTER and FINGER to design community and population-level brain health programs.”
From a policy perspective, lifestyle-based prevention could produce large cost savings, especially compared with high-priced pharmacologic treatments that often offer limited benefit and can cause side effects. Modeling studies cited by the authors estimate that reducing key risk factors by 10% to 20% per decade could lower the national burden of cognitive decline by up to 15%.
The societal costs of dementia are already immense: in 2024 nearly 12 million family members and unpaid caregivers provided an estimated 19.2 billion hours of care for people with dementia, representing a societal cost exceeding $413 billion. Caregiving also carries substantial emotional and mental health burdens, contributing to stress and burnout among caregivers. These realities underscore the urgency of scalable, community-based prevention programs that support both patients and caregivers.
“While additional research will refine best practices, the current totality of evidence supports a clear path forward: invest in lifestyle-based strategies to protect brain health,” Hennekens said. “Such investment will benefit individuals at risk and help reduce the national and global health-care burden of cognitive decline.”
The first and corresponding author of the commentary is John Dunn, a medical student at the Schmidt College of Medicine.
About this Alzheimer’s disease research news
Author: Gisele Galoustian
Source: FAU
Contact: Gisele Galoustian – FAU
Image: The image is credited to Neuroscience News
Original Research: Open access.
“Prospects for Clinicians to Reduce Cognitive Decline in Elderly Patients” by Charles H. Hennekens et al. American Journal of Medicine
Abstract
Prospects for Clinicians to Reduce Cognitive Decline in Elderly Patients
Cognitive decline is an escalating clinical and public health challenge both in the United States and globally. It includes deterioration in executive functions—memory, reasoning, attention and planning—that ranges from mild cognitive impairment to advanced dementia, including Alzheimer’s disease.
Clinicians encounter patients across this spectrum and face growing demands as populations age. Current estimates indicate about 7.2 million Americans aged 65 and older live with Alzheimer’s disease, a figure projected to rise to 13.8 million by 2060. These trends underscore the need for preventive strategies that can be implemented in clinical practice and at the population level.
Between 2000 and 2022, death rates from cardiovascular disease declined while deaths attributed to Alzheimer’s disease increased by more than 142%. Separately, evidence indicates that roughly 40% to 45% of dementia risk may be linked to modifiable environmental and lifestyle factors rather than immutable causes.
The strongest risk factor remains chronological age, but cognitive decline is not an inevitable outcome of getting older. Lifestyle contributors—physical inactivity, unhealthy diets, obesity, alcohol use, smoking, and conditions such as hypertension, dyslipidemia, diabetes and depression—along with social isolation and intellectual inactivity, all play important roles. Therapeutic lifestyle changes already recommended for cardiovascular disease and other major illnesses have the potential to reduce cognitive decline when applied to elderly patients.
Because multiple risk factors often coexist, addressing them together through multidomain lifestyle programs may produce additive benefits. If widely implemented, such interventions could yield meaningful clinical and public health gains in reducing cognitive impairment and the societal burdens that accompany it.